RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
Mohammad Aminur Rahman(Nagoya University), Dong M. Shin(Emory University), A.R.M. Ruhul Amin(Emory University), Lydia Koenig(Emory University), Zhengjia Chen(Hunan University of Traditional Chinese Medicine), Zhuo Chen(Hubei University of Medicine), Sreenivas Nannapaneni(GlaxoSmithKline (United States)), Dongsheng Wang(Qingdao University), Xingming Deng(Emory University), Zhibo Wang(Nanjing Agricultural University), Gabriel Sica(Emory University)
Cited by 137
Related Papers
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899